Latest News:
  • Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
  • CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
  • BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
  • Nextech AR Signs Poly Deal
  • Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities

Stock Day Media

Ticker Tape by TradingView

  • News
  • Radio Show
    • Be on our Show!
    • Video Interviews
  • Technology
  • Cannabis
  • Energy
  • BioTech
  • Mining
  • Contact Us
    • About Us
    • Suggestion Box
Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now

cancer

BioTech 

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021January 15, 2021 Stock Day Media 29 Views aldoxorubicin, cancer, cytrx, pancreaticcancer, phase2

CytRx Corporation (OTCQB:CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and

Read more
BioTech 

Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications

January 11, 2021January 11, 2021 Stock Day Media 84 Views cancer, cancerapplications, patentlicense, psilocybin, SILO, silopharma

Englewood Cliffs, NJ, Jan. 11, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on

Read more
BioTech 

Sunshine Biopharma Signs Licensing Agreement for Anastrozole, the Company’s First Generic Drug for Treatment of Breast Cancer

September 15, 2020September 15, 2020 Stock Day Media 1584 Views anastrozole, biopharma, cancer, sunshine, Treatment

MONTREAL, QC–(Marketwired – May 11, 2016) – Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and

Read more
BioTech 

BriaCell Files Patent Application for Novel Therapeutics for Cancer

April 27, 2020April 27, 2020 Stock Day Media 234 Views BCT, Biotech, briacells, cancer, therapeutics

BERKELEY, Calif., and VANCOUVER, British Columbia, April 27, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a

Read more
Uncategorized 

CEO Jeffery Bacha Discusses DelMar’s VOL-083 Clinical Trials and the Major Milestones Ahead

September 26, 2017September 25, 2017 Marcus Heatherly 350 Views 0 Comments biologic treatments., biotechnology stocks, cancer, cancer pharma, pharmaceutical stocks

VANCOUVER, British Columbia (Uptick Newswire – September 26, 2017) – Jeffery Bacha, CEO of DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) interviews on the

Read more
Uncategorized 

CNA Finance Initiates Research Coverage On Advanced Medical Isotope Corporation

August 24, 2017 Marcus Heatherly 351 Views 0 Comments bioscience stocks, cancer, healthcare stocks, Medical Stocks

Coral Springs, FL (Uptick Newswire – August 24, 2017) – CNA Finance Chief Research Analyst, Kenny Soulstring, today announced that

Read more
Uncategorized 

Premier Biomedical, Inc. CEO Letter – July, 2017

July 17, 2017July 14, 2017 Marcus Heatherly 404 Views 0 Comments cancer, CDB medication, healthcare, Medical Stocks, pain, pain relief

EL PASO, TX,. (Uptick Newswire – July 17, 2017) – Greetings From The CEO and Staff at Premier Biomedical, (OTC:BIEI)!

Read more
Uncategorized 

Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer Nears Commencement

July 13, 2017 Marcus Heatherly 329 Views 0 Comments biopahraceuticals, biopharma stock, cancer, development, technology

BATON ROUGE, LA–(Uptick Newswire – July 13, 2017) – OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (“OncBioMune” or the “Company”), a revenue-stage biopharmaceutical company engaged

Read more
Uncategorized 

Premier Biomedical Launches Volume Manufacture of Topical Pain Relief Products Enabling Significant Expansion of Business

June 29, 2017June 28, 2017 Marcus Heatherly 318 Views 0 Comments cancer, healthcare, hemp oil, manufacturing, Medical Marijuana, mobile technology, technology

El Paso, Texas, (Uptick Newswire – June 29, 2017) – Premier Biomedical, Inc. (OTCQB: “BIEI“) announced today that it has

Read more
Uncategorized 

Easton Pharmaceuticals Announces it has Received $400,000 USD in Product Purchase Orders for the Current Quarter from it’s Woman’s Diagnostic and Treatment Products Business for the Mexico Market

June 26, 2017 Marcus Heatherly 400 Views 0 Comments bioscience stocks, cancer, heathcare, pharmaceutical, therapeutic, treatments

TORONTO, ON., (Uptick Newswire – Jun 26, 2017) – Easton Pharmaceuticals, Inc. (OTC: EAPH), is pleased to announce it has

Read more
Uncategorized 

Pressure BioSciences Ramps Up Commercialization of Next-Generation Instrument with CE Marking — SECFilings.com

February 9, 2017February 17, 2017 Marcus Heatherly 272 Views 0 Comments cancer, medical, PBIO, Pressure Biosciences Inc

REDONDO BEACH, CA – (Uptick Newswire – February 9, 2017) – SECFilings.com, a leading financial news and information portal offering

Read more
Uncategorized 

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

January 24, 2017February 17, 2017 Marcus Heatherly 429 Views 0 Comments cancer, FDA, investing, Medical Marijuana Inc., micro cap companies, MJNA, OTC, stocks

Patient Received Permission to Be Treated with RSHO-X™ for Pain Associated with Cancer Treatment and General Well-Being SAN DIEGO, CA

Read more
  • ← Previous
Top 5 Penny Stock Picks

Latest News

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
BioTech 

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

January 15, 2021 Stock Day Media Comments Off on Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioTech 

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021 Stock Day Media Comments Off on CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
BioTech 

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

January 15, 2021 Stock Day Media Comments Off on BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
Nextech AR Signs Poly Deal
Technology 

Nextech AR Signs Poly Deal

January 15, 2021 Stock Day Media Comments Off on Nextech AR Signs Poly Deal
Copyright © 2021 Stock Day Media. All rights reserved.